Province to fund ‘observational’ study on MS treatment

The province is set to provide $1 million for an ‘observational study’ on venous procedures including the ‘Zamboni Treatment’ for people with multiple sclerosis (MS).

Local officials are pleased to see the province moving forward with the study as it will bring the entire course of the controversial treatment into sharper focus.

“We feel that it’s important to get everyone’s story and experiences,” said Lorraine Evans-Cross, executive director of the MS Society Canada – Central Alberta chapter. She said with MS affecting people so differently, the treatment outcomes tend to vary in the short, medium and long-term.

“If this opens up an avenue for more information, then that’s great.”

Paolo Zamboni, a Italian vascular surgeon, introduced the procedure last year. He believes MS is not an autoimmune condition but a vascular disease he calls ‘chronic cerebrospinal venous insufficiency’ that can be corrected by surgery.

Zamboni believes MS is caused by clogged veins, and he first performed surgery on his wife. Her MS symptoms disappeared. He later tested it on 65 patients, and 73% of them had no symptoms two years after surgery.

Provincial funds for further clinical trials will also be handed down if and when it is safe and ethical to proceed, states a release.

“In my discussions with MS patients and advocates, researchers, neurologists and other medical experts, we agreed that an observational study would be very helpful,” said Gene Zwozdesky, health and wellness minister.

The three-year study will begin next spring.

“Our government is committed to help build the body of evidence that will provide a clear indication, one way or the other, about the safety and effectiveness of this new treatment. This study is an important step in that process.”

According to the MS Society of Canada, Canadians have one of the highest rates of MS in the world and it’s the most common neurological disease affecting young adults in Canada.

Every day, three more people in Canada are diagnosed. Women are also more than three times as likely to develop MS as men.

Also, MS is unpredictable, affecting vision, hearing, memory, balance and mobility. Its effects are physical, emotional, financial, and last a lifetime. There is no cure.

Meanwhile, researchers from the University of Calgary, the University of Alberta, and other experts will conduct the study.

“This study is a response to the remarkable interest amongst MS patients in the new MS treatment proposed by Dr. Zamboni,” said Dr. Tom Feasby, dean of the University of Calgary’s faculty of medicine.

“It will help us understand the experiences of MS patients having this intervention, including any complications.”

The goal of the study is to determine the safety and patient-reported impact of chronic cerebrospinal venous insufficiency (CCSVI) treatment procedures.

To date, the venous procedures are not approved for use in Canada. Patients have flown to other countries, including Poland and India, to undergo the operation. Albertans who have received treatment for CCSVI in another country, those who are scheduled to receive it and others with MS will be eligible to participate in the study.

An MS research website and database will also be developed where Albertans can volunteer and consent to participate in the study as well as report on treatment they have received.

mweber@reddeerexpress.com

Just Posted

Klaus trial continues with cross-examination of undercover officers

The Castor-area triple homicide trial continued on Friday

Red Deer RCMP make high volume of arrests

Numerous suspects arrested in relation to property crime offences

Red Deer RCMP arrest two with multiple stolen IDs

Men had allegedly had stolen information from 15 people

Christmas Wish Breakfast helping those in need

Event takes place in Red Deer on Sunday

Temporary road closure near Riverside Drive

Red Deer road closed for water service

WATCH: Red Deer RCMP give back

United Way of Central Alberta hold inaugural McDonalds United Way Day

Dead boy’s father posts Facebook response after Appeal Court upholds conviction

David, Collet Stephan were found guilty in their son Ezekiel’s 2012 death from bacterial meningitis

Bank of Canada cautious of future rate hikes

The Bank of Canada remains cautious on future rate hikes due to low- inflation risk

London theatre received allegations against Kevin Spacey

The theatre said Thursday the 20 allegations deal with incidents between 1995 and 2013.

Da Vinci’s Christ painting sells for record $450M

The painting, “Salvator Mundi,” Latin for “Savior of the World,” is one a few paintings by Leonardo known to exist

Loblaws closing 22 stores, launching home delivery ahead of ‘difficult year’

“We are excited about our future. But…we expect 2018 will be a difficult year,” said Galen G. Weston, Loblaw CEO.

Walk of Fame bash celebrates David Suzuki, Donovan Bailey, Anna Paquin

Suzuki says he’ll be thinking of his late parents as he accepts the honour

Trudeau to personally unveil Liberals’ peacekeeping plan

This marks Canada’s first tangible step back into peacekeeping

Blake Shelton named Sexiest Man Alive 2017

“I think to describe myself as a child, one word comes to mind. And that’s fat.”

Most Read